Evidence map›Paper›PMID 32683540›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2021

The correlation of

Y-H Qu, N Long, C Ran, J Sun

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Hybrid [Bioengineering (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Relationship Between [European journal of breast health · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Evaluation of prognostic risk factors of triple-negative breast cancer withFrontiers in cell and developmental biology · 2024
    Article
  13. EJNMMI research · 2023
    Article
  14. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. The Value ofMolecular imaging and radionuclide therapy · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Y-H Qu *Department of Medical Imaging, The Affiliated Yantai Yuhuangding Hospital of Qindao University, No. 20 Yuhuangding East Road, Zhifu District, Yantai, 264000, China.
N Long *Department of Medical Imaging, The Affiliated Yantai Yuhuangding Hospital of Qindao University, No. 20 Yuhuangding East Road, Zhifu District, Yantai, 264000, China.
C Ran *Department of Medical Imaging, The Affiliated Yantai Yuhuangding Hospital of Qindao University, No. 20 Yuhuangding East Road, Zhifu District, Yantai, 264000, China.
J SunDepartment of Medical Imaging, The Affiliated Yantai Yuhuangding Hospital of Qindao University, No. 20 Yuhuangding East Road, Zhifu District, Yantai, 264000, China. jdvnh9@163.com.ORCID http://orcid.org/0000-0002-8812-4627

Funding

Shandong Medical and Health Technology Development Plan Project 2017WSB832Shandong Provincial Higher Education Research and Development Program J18KB069
6 · The paper itself

Abstract

purposeTo study the imaging parameters of

methodsFrom January 2012 to December 2014, a total of 125 female patients were treated in our hospital for the first time and were diagnosed as breast cancer by histopathology. They were selected as the research subjects. All of them had complete

resultsThe primary lesions of 125 cases with breast cancers all had higher

conclusionsThe metabolic parameters of

Indexed as

Positron Emission Tomography Computed TomographyAdultAgedArea Under CurveBreast Carcinoma In SituBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, LobularDisease-Free SurvivalFemaleFluorodeoxyglucose F18Follow-Up StudiesGlycolysisHumansMiddle AgedNeoplasm Recurrence, LocalFluorodeoxyglucose F18Radiopharmaceuticals18F-FDGBreast cancerClinicopathological factorsPET/CTPrognosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.